Clinical Trials Browser

Congenital amegakaryocytic thrombocytopenia × Alemtuzumab × Other hematologic neoplasm × Clear all

NCT00301834 2017-09-28

Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders

Classical hematologyMyeloidOther hematologic neoplasm

Congenital amegakaryocytic thrombocytopenia, Neutropenia, Severe Congenital, Autosomal Recessive 3, Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Chronic-Phase, Anemia, Diamond-Blackfan